Vir Biotechnology awarded $10 million grant by Bill & Melinda Gates Foundation to develop HIV vaccine

Vir Biotechnology awarded $10 million grant by Bill & Melinda Gates Foundation to develop HIV vaccine

Source: 
Biopharma Reporter
snippet: 

Vir Biotechnology has been awarded a new $10 million grant by the Bill & Melinda Gates Foundation to support its novel T cell vaccine development program for the prevention of HIV.